Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,221.42 -1.26 (-0.02%) Dow
39,431.51 -81.33 (-0.21%) Nasdaq
16,388.24 +47.34 (+0.29%) Bitcoin USD
62,818.48 +1,461.85 (+2.38%) CMC Crypto 200
1,293.31 +33.11 (+2.63%)
INO Jan 2025 17.000 call
| Previous close | 2.5000 |
| Open | 2.5000 |
| Bid | 2.5000 |
| Ask | 2.9500 |
| Strike | 17.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.5000 - 2.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
PR NewswireINOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the first quarter of 2024 and provided an update on recent company developments.
- PR Newswire
INOVIO Reports Inducement Grants Under Inducement Plan
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the "Inducement Plan").
- PR Newswire
INOVIO to Participate in Upcoming Investor Conferences in May
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that management will participate in the following investor conferences during the month of May:
